B-Cell Development, Somatic Recombination, and Antibody Structure

Course Logistics and Review Schedule

• Conference sections do not meet during exam week; review sessions are conducted in their place.

• Following exam week, conference sections resume on Sunday, with exceptions for recognized holidays such as Indigenous Peoples' Day.

• When Monday falls on an official holiday, Sunday and Monday sections are canceled.

• Attendance credit is obtainable by attending alternative conference sections held Tuesday through Friday of that meeting week.

Overview of B Cells and Humoral Immunity

• Lineage and Classification:

  • B cells derive from the common lymphoid progenitor (CLP) stage in hematopoiesis.

  • They are categorized as lymphocytes alongside T cells and Natural Killer (NK) cells.

  • B cells constitute a foundational arm of the adaptive immune system.

• Role in Humoral Immunity:

  • Humoral immunity is defined as antibody-mediated immune defense.

  • B cells are the sole cell type in the biological system capable of synthesizing and secreting antibodies.

  • Unlike phagocytic functions—which feature biological redundancy across macrophages and neutrophils—antibody production possesses zero cellular redundancy; loss of the B-cell lineage results in complete absence of antibodies.

• Multifunctional Attributes of B Cells:

  • Antibody Production: Synthesis of surface-bound receptors and secreted immunoglobulins.

  • Cytokine Production: Secretion of chemical messengers regulating local immune responses.

  • Antigen Presentation: Display of processed peptide fragments on cell surface molecules to engage T cells.

  • Targeted Endocytosis / Phagocytosis: B cells do not function as broad-spectrum scavenger phagocytes (unlike macrophages). They exhibit extremely selective, "picky" uptake restricted exclusively to foreign molecules that physically bind their specific B-cell receptor (BCR). Internalized antigens are then processed for antigen presentation.

Anatomy and Structural Organization of Antibodies and the BCR

• B-Cell Receptor (BCR) vs. Antibody / Immunoglobulin:

  • The BCR refers to the membrane-bound form of an antibody anchored directly into the plasma membrane of a B cell.

  • Associated adapter molecules located adjacent to the cell membrane stabilize surface expression and maintain spatial localization of the BCR complex.

  • Secreted immunoglobulins or antibodies represent the soluble counterparts of the BCR, released into plasma, lymph, or surrounding media.

  • Aside from the hydrophobic membrane-anchoring domain of the BCR, the structural anatomy of a secreted antibody and its membrane-bound BCR counterpart are virtually identical.

• Subunit Architecture:

  • An antibody monomer is a Y-shaped protein heterotetramer consisting of four polypeptide chains:

    • Two identical heavy ($H$) chains.

    • Two identical light ($L$) chains.

  • Heavy chains possess a greater molecular mass and higher amino acid count than light chains.

  • Heavy and light chains are encoded by separate gene loci located on distinct chromosomes, requiring independent translation followed by coordinated quaternary assembly.

  • Analogous to the four globin subunits assembling to form functional hemoglobin, heavy and light chains cannot execute antigen binding in isolation; both chains must assemble cooperatively to generate the binding site.

• Variable ($V$) and Constant ($C$) Regions:

  • Constant Region ($C$): Amino acid and nucleotide sequences are invariant across B cells of the same isotype. Constant regions form the stem and structural scaffolding.

  • Variable Region ($V$): Displays extreme sequence variation between distinct B-cell clones. Composed of approximately the first $110$ amino acids starting from the amino-terminal ($N$-terminal) end of both the heavy and light chains.

  • The pairing of the heavy-chain variable domain ($V_H$) and light-chain variable domain ($V_L$) generates the physical antigen-binding pocket.

• Antigen-Antibody Interface Terminology:

  • Epitope: The specific chemical epitope or steric site on the antigen recognized by the antibody.

  • Paratope (Antigen-Binding Site): The specialized complementary surface on the antibody variable region that engages the epitope via a lock-and-key dynamic.

• Chemical Stabilization:

  • Polypeptide chains are held together by covalent interchain disulfide bonds (disulfide bridges).

  • These bonds form between sulfhydryl groups of juxtaposed cysteine residues across heavy-heavy and heavy-light junctions.

• Light Chain Isotypes:

  • Light chains exist as either Kappa ($\kappa$) or Lambda ($\lambda$) chains.

  • During B-cell development, rearrangement follows the "$\kappa$-first rule," whereby the $\kappa$ locus undergoes recombination first. If the resulting receptor fails productive signaling or demonstrates autoreactivity, the cell accesses the $\lambda$ locus as a secondary option.

• Chain Polarity:

  • Each chain possesses an amino terminus ($N$ -terminus) at the variable antigen-binding end and a carboxyl terminus ($C$-terminus) at the base of the constant region.

The Immunogenetic Paradox and Somatic Recombination Theory

• Historical Context and the Genetic Dilemma (1970s–1980s):

  • Structural sequencing established that individual B cells generate antibodies with unique amino acid sequences within their initial $110$ amino-terminal residues.

  • The total human immunoglobulin repertoire can generate approximately $10^{11}$ (100 billion) distinct antibody variants.

  • In contrast, the human genome comprises approximately $20{,}000$ to $30{,}000$ protein-coding genes.

  • Standard cellular mechanisms such as alternative pre-mRNA splicing or post-translational modifications could not mathematically bridge the gap between $20{,}000$ genes and $10^{11}$ distinct protein products.

• Germline Theory vs. Somatic Recombination Theory:

  • Germline Theory: Proposed that each distinct antibody chain was encoded by a dedicated, pre-existing gene in the inherited germline genome ("one gene, one protein"). This hypothesis was discarded due to genomic capacity constraints.

  • Somatic Recombination Theory (Susumu Tonegawa): Postulated that immunoglobulin genes exist in the germline as discontinuous gene segments. During B-cell ontogeny, somatic DNA permanently undergoes cut-and-paste genomic rearrangements, physically altering the chromosome to generate an expansive antibody repertoire from a restricted set of inherited gene segments.

The Hozumi and Tonegawa Experiment

• Experimental Design:

  • Designed to demonstrate whether immunoglobulin genes undergo physical rearrangement at the genomic DNA level in B cells compared to non-lymphoid somatic cells.

  • Cell Models Evaluated:

    • Embryonic / non-lymphoid liver cells (representing the unrearranged germline genome).

    • Antibody-producing B-cell lines (myeloma / B-cell tumor cells representing differentiated, antigen-committed lymphocytes).

• Procedural Methodology:

  1. High molecular weight genomic DNA was extracted separately from liver cells and B-cell tumors.

  2. DNA was digested using the restriction endonuclease BamHI (BamH I), which cleaves double-stranded DNA at sequence-specific palindromic recognition sites.

  3. Digested fragments were separated by size via agarose gel electrophoresis, where negatively charged nucleic acids migrate toward the positive anode (small fragments travel rapidly and migrate further down the gel/tube, whereas large fragments migrate slowly near the top).

  4. Fractions were hybridized using radioactive probes:

     • A whole light chain probe complementary to both the variable ($V$) and constant ($C$) regions.

     • A specific constant ($C$) region probe complementary solely to the $3'$ end.

• Results and Observations:

  • Germline (Liver / Embryonic) DNA:

    • When hybridized with the whole light chain probe, two distinct large DNA fragments were observed as two separate peaks/bands high up on the migration axis.

    • This dual-band pattern occurred because an unmutated BamHI cleavage site naturally sits within the intervening germline DNA separating the $V$ and $C$ gene segments.

    • Hybridization with the isolated $C$-region probe yielded a single, large high-molecular-weight band corresponding to the downstream restriction fragment.

  • Differentiated B-Cell DNA:

    • When hybridized with the whole light chain probe, a single, significantly smaller fragment was detected, migrating substantially further down the gel.

    • Hybridization with the $C$-region probe bound the exact same smaller fragment.

• Mechanistic Conclusions:

  • In functional B cells, the intervening non-coding DNA segment—which contained the internal BamHI cleavage site—had been permanently excised from the chromosome.

  • The $V$ gene segment had been physically translocated immediately adjacent to the $C$ gene segment at the DNA level, creating a unified, shortened coding fragment and validating somatic DNA recombination.

Genomic Architecture of Immunoglobulin Loci

• Gene Segment Terminology:

  • $V$: Variable gene segment.

  • $D$: Diversity gene segment (present exclusively in the heavy chain locus).

  • $J$: Joining gene segment.

  • $C$: Constant region gene.

• Light Chain Locus Architecture ($V-J-C$):

  • Contains multiple independent $V$ segments, multiple $J$ segments, and downstream $C$ exons (lacks $D$ segments).

  • The human $\kappa$ light chain locus contains approximately $41$ functional $V$ segments.

  • Undergoes a single somatic rearrangement bringing one $V$ segment directly adjacent to one $J$ segment ($V \rightarrow J$ joining).

• Heavy Chain Locus Architecture ($V-D-J-C$):

  • Contains approximately $45$ functional $V$ segments, $23$ functional $D$ segments, multiple $J$ segments, and constant region clusters ($C_H$).

  • Undergoes a two-step somatic rearrangement:

    1. $D \rightarrow J$ joining.

    2. $V \rightarrow DJ$ joining.

• Combinatorial Diversity:

  • Random mathematical assortment of single $V$, $D$, and $J$ segments, combined with the independent pairing of varied heavy and light chains, yields approximately $2 \times 10^6$ (2 million) possible baseline antibody specificities prior to additional enzymatic diversification.

Enzymatic Machinery and Step-by-Step Mechanism of V(D)J Recombination

• Recombination Signal Sequences (RSS):

  • Conserved DNA motifs flanking every functional $V$, $D$, and $J$ coding segment acting as precise landmarks for recombination enzymes.

  • Structure consists of:

    • A conserved heptamer ($7\text{-bp}$ sequence).

    • An intervening non-conserved spacer of either $12\text{-bp}$ or $23\text{-bp}$ in length.

    • A conserved nonamer ($9\text{-bp}$ sequence).

  • Spacers align the DNA turns to ensure proper spatial orientation of the cleavage machinery.

• Enzymatic Steps of Recombination:

  • Step 1: Recognition and Cleavage by RAG-1 and RAG-2:

    • Recombination-Activating Gene 1 and 2 proteins form a stable multi-protein recombinase complex ($\text{RAG-1/2}$).

    • $\text{RAG-1/2}$ binds specifically to the RSS motifs flanking target segments, looping out the intervening genomic DNA.

    • The complex induces a clean double-strand break (DSB) precisely at the junction between the RSS and the coding segment.

    • $\text{RAG1}^{-/-}$ or $\text{RAG2}^{-/-}$ knockout mice are completely devoid of mature B cells and T cells due to total arrest of receptor recombination.

  • Step 2: Formation of Coding Hairpins and Excision Circles:

    • Cleavage of the coding ends creates covalently sealed DNA hairpins at both segment borders.

    • The excised intervening genomic DNA circularizes into a closed loop termed an excision circle, which is permanently discarded and diluted during cell division. These circles can be quantified in clinical newborn screenings to assess early lymphocyte development.

  • Step 3: End-Binding by Ku70 and Ku80:

    • The heterodimer Ku70/Ku80 binds rapidly to both open double-stranded DNA ends.

    • Acting as a structural scaffold or "tool belt," Ku70/80 stabilizes the break and recruits downstream non-homologous end joining (NHEJ) repair enzymes.

    • $\text{Ku70}^{-/-}$ and $\text{Ku80}^{-/-}$ knockout animal models exhibit severe combined B- and T-cell deficiencies.

  • Step 4: Hairpin Opening by Artemis:

    • The Artemis endonuclease is recruited and phosphorylated to open the covalently sealed DNA hairpins.

    • Artemis introduces an asymmetric, non-central nick into each hairpin, yielding single-stranded DNA overhangs of variable length.

  • Step 5: Palindromic (P) Nucleotide Addition:

    • DNA polymerases repair the asymmetric single-stranded overhangs by filling in complementary nucleotides, producing blunt ends.

    • Because these bases are templated by the inverted cleavage of the original sequence, they create palindromic sequences termed P-nucleotides.

  • Step 6: Exonuclease Trimming and Non-Templated (N) Nucleotide Addition:

    • In heavy chain rearrangements, an exonuclease chews back terminal nucleotides, removing bases randomly from the coding ends.

    • Terminal deoxynucleotidyl transferase (TdT) randomly incorporates non-templated nucleotides (N-nucleotides) onto the single-stranded ends without a DNA template.

  • Step 7: Ligation:

    • DNA Ligase IV, complexed with XRCC4, seals the modified DNA backbones together to establish a permanently recombined coding joint.

• Mechanisms of Junctional Diversity:

  • While combinatorial diversity accounts for approximately $2 \times 10^6$ variants, junctional diversity amplifies total antibody potential to approximately $10^{11}$ variants.

  • Driven by three randomized enzymatic actions at the coding joint:

    1. Asymmetric cleavage sites induced by Artemis.

    2. Uncontrolled exonucleolytic chewing-back of terminal bases.

    3. Random addition of N-nucleotides by TdT.

  • This sequence flexibility ensures that two distinct B cells utilizing the exact same germline $V$, $D$, and $J$ segments will encode divergent amino acid sequences across their antigen-binding junctions.

Stages of B-Cell Differentiation

• Ontogeny Overview:

  • Hematopoietic Stem Cell (HSC) $\rightarrow$ Pro-B Cell $\rightarrow$ Pre-B Cell $\rightarrow$ Immature B Cell (in bone marrow) $\rightarrow$ Mature Naive B Cell (in peripheral secondary lymphoid organs).

• Pro-B Cell Stage:

  • Initiation of somatic recombination at the heavy-chain immunoglobulin locus.

  • The locus undergoes $D \rightarrow J$ rearrangement first, followed immediately by $V \rightarrow DJ$ rearrangement.

  • Light chain loci remain in their germline, unrearranged configuration.

  • No functional BCR components are expressed on the outer plasma membrane.

• Pre-B Cell Stage:

  • The productively rearranged heavy chain is translated and escorted to the cell surface.

  • Because light chain rearrangement has not occurred, the heavy chain pairs with an invariant surrogate light chain, forming the Pre-BCR complex.

  • Surface expression of the Pre-BCR initiates essential intracellular signaling cascades:

    • Suppresses further heavy chain rearrangement (mediating allelic exclusion).

    • Initiates somatic rearrangement of the light chain locus ($V_L \rightarrow J_L$), commencing with the $\kappa$ locus.

• Immature B-Cell Stage:

  • Successful assembly of a genuine light chain with the heavy chain produces a complete, functional IgM BCR on the plasma membrane.

  • Immature B cells undergo stringent central tolerance testing within the bone marrow to eliminate or reprogram autoreactive clones recognizing self-antigen.

• Mature B-Cell Migration:

  • Non-autoreactive immature B cells exit the bone marrow and enter peripheral circulation.

  • Approximately $75\%$ of mature naive B cells traffic directly to the spleen, with remaining populations circulating through the blood, lymph nodes, and mucosa-associated lymphoid tissue (MALT).

  • Mature B cells can survive and navigate to alternative secondary lymphoid tissues in individuals who have undergone splenectomy.

The Bone Marrow Microenvironment and Cytokine Cues

• The Perivascular Niche:

  • Hematopoietic stem cells and developing B cells reside primarily within the perivascular cavities of the bone marrow.

  • This specialized microenvironment is physically flanked by bony trabeculae on one side and vascular endothelial cells on the other, supplying developing precursors with nutrients, oxygen, and circulatory signals.

• Stromal Cell Support:

  • Bone marrow stromal cells serve as a non-lymphoid cellular scaffold essential for survival, lineage commitment, and proliferation.

  • Stromal cells regulate local pH and express critical membrane-bound signaling molecules and cytokines.

• CXCL12 / CXCR4 Retention and Egress Axis:

  • Stromal cells express the chemokine CXCL12 directly on their cell surface.

  • Pro-B and Pre-B cells express high surface densities of the chemokine receptor CXCR4, anchoring them physically to CXCL12-expressing stromal niches during gene rearrangement.

  • As cells transition to the immature B-cell stage, they downregulate CXCR4 expression, breaking stromal attachment and permitting functional egress from the bone marrow into the peripheral circulation.

• Interleukin-7 (IL-7) Lineage Induction:

  • Specialized stromal cells display the cytokine Interleukin-7 (IL-7) bound to their membranes.

  • Ligation of stromal IL-7 to IL-7 receptors on lymphoid progenitors delivers critical intracellular phosphorylation cascades that drive B-cell lineage commitment, promote survival gene expression, and upregulate the V(D)J recombination machinery.

Questions & Discussion

• Conference Section Attendance and Holiday Policies:

  • Question: If a student attends an alternate conference section during an exam week, does it count toward the course attendance grade?

  • Clarification: Conference sections do not meet during exam week due to scheduled review sessions. The following week, sections scheduled for Sunday and Monday are canceled in observance of Indigenous Peoples' Day. Students attending any section from Tuesday through Friday during that week receive full attendance credit.

• Structural and Functional Distinction Between Heavy and Light Chains:

  • Question: What is the functional and physical difference between heavy and light chains, and do they operate independently?

  • Clarification: Heavy and light chains differ significantly in molecular weight, total amino acid count, and chromosomal origins. They do not operate independently. Like the globin chains of hemoglobin, they function cooperatively: their variable domains assemble together to form the antigen-binding pocket.

• Human Genome Coding Capacity:

  • Question: Why does modern genomic data estimate only around $20{,}000$ to $30{,}000$ human genes, and does an apparent drop in estimated gene count hold biological significance?

  • Clarification: The decrease reflects historical refinements in genome annotation techniques rather than a biological alteration. The critical immunological principle is the immense mathematical disparity between possessing approximately $20{,}000$ baseline genes and producing more than $10^{11}$ unique antibody proteins.

• Ku Protein Identification:

  • Question: Clarification on the specific numbering of the Ku family proteins recruited to double-strand breaks.

  • Clarification: The physiological repair heterodimer consists strictly of Ku70 and Ku80 (not Ku90), which form a scaffold across double-stranded DNA breaks to recruit the non-homologous end joining repair machinery.

• Consequences of Aberrant Recombination:

  • Question: What occurs if the random addition and trimming of nucleotides generates nonfunctional or out-of-frame antibody genes?

  • Clarification: Imprecise enzymatic cutting and joining frequently yields out-of-frame nonsense mutations or truncated, nonfunctional receptors. Cells bearing nonfunctional rearrangements fail to receive positive survival signals through the Pre-BCR or BCR and undergo apoptotic death in the bone marrow before reaching the peripheral circulation.